STOCK TITAN

Albemarle Corporation (ALB) Stock Price, News & Analysis

ALB NYSE
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
33 252 sessions, November 13, 2025 to November 13, 2026
Largest daily move
+16.3% close of April 16, 2026
1-year change
-18.4% closing prices, November 13, 2025 to November 13, 2026
1-month change
-4.2% closing prices, October 13, 2026 to November 13, 2026

Company Description

Albemarle Corporation (NYSE: ALB) is described as a global leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. The company states that it partners with customers to pioneer ways to move, power, connect and protect "with people and planet in mind." A reliable and high-quality global supply of lithium and bromine underpins Albemarle’s ability to deliver advanced solutions to its customers.

According to available information, Albemarle is one of the world’s largest lithium producers and a fully integrated lithium company. Its lithium business includes upstream resources in salt brine deposits and hard rock mines, as well as lithium refining plants. The company also reports that it is a global leader in the production of bromine, which is used in flame retardants and other specialty applications. These activities align with Albemarle’s stated focus on essential elements that support mobility, energy systems, digital connectivity and various health-related uses.

Albemarle is incorporated in Virginia and its common stock trades on the New York Stock Exchange under the symbol ALB. Public disclosures and news releases indicate that the company operates on a global basis and emphasizes a reliable supply of lithium and bromine for its customers. Albemarle also regularly communicates that it is focused on operational excellence, cost and productivity improvements, and portfolio management actions intended to support its long-term strategy.

Business focus and resources

Albemarle’s business is centered on transforming natural resources into lithium and bromine-based products and related solutions. The company highlights lithium as an energy storage material used in batteries, particularly for applications related to mobility and energy. Its bromine activities support flame retardants and other specialty uses tied to connectivity and protection.

Albemarle has described itself as having upstream resources including salt brine deposits and hard rock mines, as well as lithium refining plants in multiple countries. These assets support its role as a fully integrated lithium producer. The company’s communications emphasize that this integrated structure and global footprint are important to providing a reliable and high-quality supply to customers.

Segments and portfolio actions

In its public reporting, Albemarle discusses results and outlook for areas such as Energy Storage, Specialties and Ketjen. Energy Storage relates to lithium-based materials used in energy applications. Specialties includes products such as flame retardants that benefit from bromine chemistry and serve end markets like electrical and electronics applications. Ketjen is described as a business focused on refining catalyst solutions and related technologies.

Albemarle has announced portfolio actions involving Ketjen and its interest in the Eurecat joint venture. The company entered into agreements to sell a controlling stake in Ketjen’s refining catalyst solutions business to an affiliate of KPS Capital Partners while retaining an ownership interest, and to sell its 50% stake in the Eurecat joint venture to Axens SA. Albemarle has indicated that these transactions are intended to strengthen its financial flexibility, focus on core businesses and streamline operations, while it continues to own and participate in certain catalyst-related activities through retained interests.

Organizational structure and strategy

Albemarle has described enhancements to its organizational structure intended to align the company for greater agility and efficiency. The company has created integrated functions that bring together resources, manufacturing, capital projects and supply chain, and has highlighted roles focused on enterprise strategy, growth, research and technology, as well as people and workplace transformation. These changes are presented as supporting a market-led enterprise strategy and operational excellence.

In earnings-related disclosures, Albemarle has highlighted cost and productivity improvement programs, capital expenditure adjustments, and portfolio management steps such as the Ketjen and Eurecat transactions. The company has also discussed its approach to managing liquidity, debt levels and free cash flow, indicating an emphasis on financial flexibility alongside its operational and strategic initiatives.

Governance and public company status

Albemarle files reports with the U.S. Securities and Exchange Commission as a public company. Recent Form 8-K filings have covered topics such as quarterly results, material definitive agreements, organizational changes, director and officer changes, and expected goodwill impairment charges related to portfolio transactions. These filings show that Albemarle remains an SEC-reporting issuer with common stock listed on the NYSE.

The company also notes that it regularly posts information on its website, including events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information about its businesses and the markets it serves. Earnings releases are typically accompanied by conference calls and webcasts for analysts and investors.

Role in lithium, bromine and critical minerals

Albemarle’s public descriptions emphasize its role in lithium and bromine as essential elements that support broader trends in mobility, energy, connectivity and health. Lithium is highlighted as a key material for energy storage, while bromine supports flame retardants and other specialty applications. External commentary in the provided data also refers to Albemarle as one of the leading critical mineral companies in the world, with a leading position in lithium and cesium.

Through offtake and prepayment agreements with other companies, Albemarle participates in arrangements that relate to critical minerals such as cesium. These agreements are presented as part of broader efforts in the critical minerals supply chain connected to electrification and decarbonization themes.

Stock Performance

$93.53
-1.39%
-1.32
Last updated: November 13, 2026 at 16:00
-18.4%
Performance 1 year
$11.0B

Albemarle Corporation (ALB) closed at $93.53 on November 13, 2026. Over the past 12 months, the price has lost 18.4%.

See what a $1,000 investment in ALB would be worth today

Average down calculator for ALB

ALB Metrics & Rankings

Price returns through November 13, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Albemarle Corporation has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, dividends, earnings date, management. View all ALB news →

Financial Highlights

Albemarle Corporation generated $5.1B in revenue in FY2025, retaining a 13.0% gross margin, operating income reached -$367.1M (-7.1% operating margin), and net income was -$510.6M, reflecting a -9.9% net profit margin. Diluted earnings per share stood at -$5.76. The company generated $1.3B in operating cash flow. The current ratio was 2.23, measuring current assets divided by current liabilities.

$5.1B
Revenue (FY2025)
-$510.6M
Net Income (FY2025)
$1.3B
Operating Cash Flow

Upcoming Events

DEC
18
December 18, 2026 Financial

Dividend record date

Shareholders of record at close on Dec 18, 2026 will be eligible to receive Albemarle's $0.41 per share quarterly dividend.
JAN
04
January 4, 2027 Financial

Dividend payment

Quarterly common dividend of $0.41 per share payable to holders of record on Dec 18, 2026; payment on Jan 4, 2027.
FEB
01
February 1, 2027 Corporate

CEO start date

Ragnar Udd becomes Albemarle CEO and joins the Board effective Feb 1, 2027; Kent Masters moves to Executive Chairman.

Albemarle Corporation has 3 upcoming scheduled events. The next event, "Dividend record date", is scheduled for December 18, 2026 (in 35 days). 2 of them are financing or capital events, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the ALB stock price.

Short Interest History

Last 12 Months

Short interest in Albemarle Corporation (ALB) currently stands at 12.4 million shares, up 1.2% from the previous reporting period, representing 10.5% of the float. Since November 2025, short interest has increased by 14.3%.

Days to Cover History

Last 12 Months

Days to cover for Albemarle Corporation (ALB) currently stands at 5.3 days, up 6.7% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 103.9%. Across the settlements charted above, it has ranged from 2.2 to 6.5 days.

ALB Company Profile & Sector Positioning

Albemarle Corporation (ALB) operates in the Specialty Chemicals industry within the broader Basic Materials sector and is listed on the NYSE. Among dividend-paying stocks, ALB ranks #1,407 by dividend yield.

Investors comparing ALB often look at related companies in the same sector, including RPM International, Inc. (RPM), Sociedad Quimica y Minera de Chile SA (SQM), LyondellBasell Industries N.V. (LYB), DuPont de Nemours, Inc. (DD), and International Flavors & Fragrances Inc. (IFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ALB's relative position within its industry.

Frequently Asked Questions

The current stock price of Albemarle Corporation (ALB) is $93.53 as of November 13, 2026.

The market cap of Albemarle Corporation (ALB) is approximately $11.0B. Learn more about what market capitalization means .

The FY2025 revenue of Albemarle Corporation (ALB) is $5.1B, from its most recent completed fiscal year.

The FY2025 net income of Albemarle Corporation (ALB) is -$510.6M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Albemarle Corporation (ALB) is -$5.76 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Albemarle Corporation (ALB) is $1.3B for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Albemarle Corporation (ALB) is -9.9% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Albemarle Corporation (ALB) is -7.1% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Albemarle Corporation (ALB) is 13.0% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Albemarle Corporation (ALB), current assets divided by current liabilities, was 2.23 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Albemarle Corporation (ALB) is $668.7M for FY2025, its most recent completed fiscal year.

The operating income of Albemarle Corporation (ALB) is -$367.1M for FY2025, its most recent completed fiscal year. Learn about operating income.

Albemarle Corporation focuses on transforming essential resources into critical ingredients for mobility, energy, connectivity and health. It emphasizes a reliable global supply of lithium and bromine that supports advanced solutions for its customers.

The available information describes Albemarle as one of the world’s largest lithium producers and a fully integrated lithium company, with upstream resources and lithium refining plants that support energy storage applications.

Albemarle states that it is a global leader in bromine production. Bromine is used in flame retardants and other applications that contribute to connectivity and protection, aligning with the company’s focus on essential elements.

Albemarle’s common stock is listed on the New York Stock Exchange under the ticker symbol ALB.

Albemarle highlights a market-led enterprise strategy focused on operational excellence, cost and productivity improvements, and portfolio management actions that support its core businesses and financial flexibility.

Ketjen is a subsidiary of Albemarle that develops, manufactures and markets catalysts and related products. Albemarle has agreed to sell a controlling stake in Ketjen’s refining catalyst solutions business to an affiliate of KPS Capital Partners while retaining an ownership interest.

Eurecat is a joint venture in which Ketjen held a 50% interest. Albemarle has disclosed that Ketjen entered into an agreement for the sale of this interest to Axens SA, with Albemarle expecting to receive cash proceeds as part of its broader portfolio actions.

Albemarle issues earnings press releases, files reports such as Form 8-K with the SEC, and hosts conference calls and webcasts to discuss its quarterly and other results. It also posts related information, including investor presentations and non-GAAP reconciliations, on its website.